chemotherapy: be done before surgery

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be done before surgery 1.00
be used before surgery 0.96
be given before surgery 0.95
be used after surgery 0.94
be given after surgery 0.92
is surgery 0.91
is major surgery 0.88
be done 0.82
is done 0.81
be given after mastectomy 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 0.88
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.43
¬ Remarkable(mastectomy, is major surgery)
0.04
Rule weight: 0.13
Evidence weight: 0.33
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.85
¬ Remarkable(mastectomy, is done)
0.03
Rule weight: 0.13
Evidence weight: 0.27
Similarity weight: 0.91
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.93
¬ Remarkable(mastectomy, is surgery)
0.03
Rule weight: 0.13
Evidence weight: 0.30
Similarity weight: 0.82
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.90
¬ Remarkable(gene therapy, be done)
0.03
Rule weight: 0.13
Evidence weight: 0.27
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.92
¬ Remarkable(dialysis, is done)
0.03
Rule weight: 0.13
Evidence weight: 0.26
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.95
¬ Remarkable(gene therapy, is done)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.91
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.93
Remarkable(mastectomy, is surgery) ⋁
Evidence: 0.20
¬ Plausible(mastectomy, is surgery)
0.49
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.82
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.90
Remarkable(gene therapy, be done) ⋁
Evidence: 0.23
¬ Plausible(gene therapy, be done)
0.49
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.81
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.95
Remarkable(gene therapy, is done) ⋁
Evidence: 0.24
¬ Plausible(gene therapy, is done)
0.48
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.92
Remarkable(dialysis, is done) ⋁
Evidence: 0.36
¬ Plausible(dialysis, is done)
0.48
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.85
Remarkable(mastectomy, is done) ⋁
Evidence: 0.32
¬ Plausible(mastectomy, is done)
0.47
Rule weight: 0.60
Evidence weight: 0.89
Similarity weight: 0.88
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.43
Remarkable(mastectomy, is major surgery) ⋁
Evidence: 0.71
¬ Plausible(mastectomy, is major surgery)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.87
¬ Salient(chemotherapy, be done before surgery)

Similarity expansion

0.79
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.94
Evidence: 0.70
Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.03
¬ Typical(chemotherapy, be used after surgery)
0.77
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.92
Evidence: 0.70
Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.06
¬ Typical(chemotherapy, be given after surgery)
0.77
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.96
Evidence: 0.70
Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.21
¬ Typical(chemotherapy, be used before surgery)
0.75
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.94
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.23
¬ Plausible(chemotherapy, be used after surgery)
0.75
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.96
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.65
¬ Salient(chemotherapy, be used before surgery)
0.74
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.94
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.53
¬ Salient(chemotherapy, be used after surgery)
0.73
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.92
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.55
¬ Salient(chemotherapy, be given after surgery)
0.73
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.92
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.27
¬ Plausible(chemotherapy, be given after surgery)
0.73
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.95
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.72
¬ Salient(chemotherapy, be given before surgery)
0.73
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.96
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.40
¬ Plausible(chemotherapy, be used before surgery)
0.70
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.95
Evidence: 0.70
Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.44
¬ Typical(chemotherapy, be given before surgery)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.95
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.53
¬ Plausible(chemotherapy, be given before surgery)
0.68
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.70
Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.06
¬ Typical(chemotherapy, is done)
0.67
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.80
Evidence: 0.70
Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.04
¬ Typical(chemotherapy, be given after mastectomy)
0.66
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.95
Evidence: 0.79
Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.84
¬ Remarkable(chemotherapy, be given before surgery)
0.66
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.96
Evidence: 0.79
Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.92
¬ Remarkable(chemotherapy, be used before surgery)
0.64
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.81
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.53
¬ Salient(chemotherapy, is done)
0.64
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.81
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.26
¬ Plausible(chemotherapy, is done)
0.63
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.80
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.26
¬ Plausible(chemotherapy, be given after mastectomy)
0.63
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.80
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.56
¬ Salient(chemotherapy, be given after mastectomy)
0.63
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.94
Evidence: 0.79
Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery)
0.62
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.92
Evidence: 0.79
Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.96
¬ Remarkable(chemotherapy, be given after surgery)
0.55
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.81
Evidence: 0.79
Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.96
¬ Remarkable(chemotherapy, is done)
0.54
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.80
Evidence: 0.79
Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.87
Salient(chemotherapy, be done before surgery) ⋁
Evidence: 0.70
¬ Typical(chemotherapy, be done before surgery) ⋁
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.72
Plausible(chemotherapy, be done before surgery) ⋁
Evidence: 0.70
¬ Typical(chemotherapy, be done before surgery)

Typicality and Rermarkability incompatibility between siblings

0.12
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 0.91
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.04
¬ Typical(mastectomy, is surgery)
0.11
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 0.82
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.07
¬ Typical(gene therapy, be done)
0.11
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.06
¬ Typical(gene therapy, is done)
0.10
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.14
¬ Typical(dialysis, is done)
0.10
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.16
¬ Typical(mastectomy, is done)
0.04
Rule weight: 0.14
Evidence weight: 0.36
Similarity weight: 0.88
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery) ⋁
Evidence: 0.81
¬ Typical(mastectomy, is major surgery)